• About
  • Subscribe
  • Advertise
  • Contact
Saturday, February 14, 2026
Newsletter
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
Home

Don’t make these social media mistakes

by Staff Writer
January 5, 2018
in Company updates & acquisitions
Reading Time: 4 mins read
A A
Share on FacebookShare on Twitter

Despite being a specialist in social media managent, Buffer has committed a good number of social media mistakes, errors that have cost the business reach, engagent and maybe even customers.In an effort to prevent independent optometry practices from committing the same mistakes, here is an overview of some of the social media mishaps made by Buffer and how they can be avoided.Content overloadFocusing on quantity over quality – Just last year, Buffer was posting four to five times to its Facebook page and tweeting up to 14 times per day.Having enough material to share was never the probl, as much content was being produced on blogs and podcasts; however, we noticed that the reach and engagent of our posts increased three-fold when we cut posting to once or twice per day.Limiting Facebook posts to just two per day forced us to share only our very best content. The higher-quality posts resonated with our Facebook fans and the Facebook algorithm surfaced th to more people.Optometry practice owners don’t have the time to create or find enough high-quality content to post five times a day on Facebook or tweet 10 times a day on Twitter. By reducing the number of times a practice posts each day, it can focus on the quality of its posts rather than the quantity.Spread too thin{{quote-A:R-W:450-Q: Take stock of social media profiles and consider which channels are performing for your business and which are not }}Spreading across all social media platforms – As a social media managent company, the Buffer teams feels a duty to test out all social media platforms so that they can understand how each platform works. We then share what we’ve learned about succeeding on each platform, but what we haven’t been so great at doing is deciding when to stop using a certain platform.It was only when Instagram introduced a similar feature called Stories that we gradually stopped posting to Snapchat and focused instead on Instagram.For the time and effort we put into Snapchat, Buffer wasn’t getting the results and most of the users on Snapchat weren’t our target audience anyway.Instagram, on the other hand, provides several advantages such as better discoverability, analytics (including audience insights) and audience targeting through ads.Every additional platform a business incorporates will require additional time and effort to create great tailored content for that platform.Take stock of social media profiles and consider which channels are performing for your practice and which are not.By moving away from social media platforms that might not suit a business or those that are not performing well, businesses can double down on those that are.Wrong orientationUsing only landscape videos and images – We were accustomed to posting landscape videos and images because that was the ideal image size for most social media platforms, such as Facebook and Twitter (1,024 pixels by 512 pixels); however, that might not be true anymore.As square videos and images are no longer cropped on Facebook and Twitter, they take up more real estate on someone’s feed – 78% more, in fact.After spending $1,500 on experiments, Buffer found that square videos actually generate higher average views and greater engagent than landscape videos, especially on mobile phones.Another fun experiment to explore might be posting vertical (portrait) videos and images, especially since Facebook is showing a larger preview of vertical videos on its mobile feed.No showNot uploading videos onto social media platforms – Quintly, a business that provides social media analytics tools, analysed more than six million Facebook posts and found that videos uploaded to Facebook receive more engagent and shares than YouTube videos on Facebook.“The interaction rate for Facebook native videos were on average 109.67% higher than for YouTube videos,” Quintly reported. “Facebook native videos had on average a 477.76% higher share rate compared to YouTube videos.”Just a year ago, the Buffer team was still sharing YouTube links to videos rather than uploading videos onto social media platforms.When YouTube links were posted, the best video post only reached 3,397 people. Now, videos uploaded onto Facebook receive an average reach of 53,254.Hopefully there are takeaways here for small businesses and practice owners looking to improve their social media strategies. The second part of this series will reveal more mistakes, as well as the lessons learnt.More reading: Part 2 – More social media mistakes to avoid

Related Posts

The International Red Light Ophthalmic Society (IRLOS) was formerly launched at the 41st Asia-Pacific Academy of Ophthalmology (APAO) Congress. Image: Eyerising

APAO 2026: Red light therapy moves into the global spotlight

by Staff Writer
February 13, 2026

The 41st Asia-Pacific Academy of Ophthalmology (APAO) Congress, held on 5–8 February 2026 in Hong Kong, marked a defining moment...

A Belgian firm has taken a big stake in Rayner. Image: Rayner.

Firm spending $840 million for big stake in Rayner

by Rob Mitchell
February 11, 2026

Belgian investment holding company Groupe Bruxelles Lambert (GBL) is investing €500 million (AU$840  million) in British ophthalmic manufacturer Rayner. An...

Melbourne-based BHG Capital has reportedly agreed a 50% stake in Two Svge. Image: vichie81/stock.adobe.com.

Investor takes big stake in up-and-coming WA eyewear company

by Staff Writer
February 10, 2026

Victorian fund BGH Capital has reportedly taken a nearly 50% stake in Perth-born Two Svge, a direct-to-consumer supplier of bold...

Join our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

Insight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.

Subscribe to our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

About Insight

  • About
  • Advertise
  • Subscribe
  • Contact
  • Terms & Conditions
  • Privacy Collection Notice
  • Privacy Policy

Popular Topics

  • Business
  • Feature
  • Research
  • Technology
  • Therapies
  • Classifieds

© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited

No Results
View All Results
NEWSLETTER
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
  • About Us
  • Advertise with Insight
  • Subscribe
  • Contact Insight

© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited